We are live on
!
Find out more
ARTA
A.R.T. Advisors Portfolio holdings
AUM
$1.79M
1-Year Est. Return
57.47%
This Fund
S&P 500
This Quarter
Est. Return
-9.43%
1 Year Est. Return
+57.47%
3 Year Est. Return
+81.79%
5 Year Est. Return
+178.88%
10 Year Est. Return
–
AUM
$2.7B
AUM Growth
-$296M
(-9.9%)
Cap. Flow
+$44.6M
Cap. Flow
% of AUM
1.65%
Top 10 Holdings %
Top 10 Hldgs %
8.27%
Holding
1,895
New
457
Increased
377
Reduced
454
Closed
575
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$26.9M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$24.9M |
| 3 |
PARA
Paramount Global Class B
PARA
|
+$19.8M |
| 4 |
Morgan Stanley
MS
|
+$18.5M |
| 5 |
Kraft Heinz
KHC
|
+$16.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cencora
COR
|
+$22.3M |
| 2 |
Amgen
AMGN
|
+$21.9M |
| 3 |
Alibaba
BABA
|
+$18.9M |
| 4 |
SLB Ltd
SLB
|
+$18M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$14.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.76% |
| 2 | Technology | 13.33% |
| 3 | Consumer Discretionary | 12.45% |
| 4 | Industrials | 11.02% |
| 5 | Financials | 9.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Canadian Imperial Bank of Commerce
CM
$109B
| $1.86M | 0.07% |
51,716
+19,048
| +58% | +$674K |
|
402
Interactive Brokers
IBKR
$40.5B
| $1.86M | 0.07% |
+188,500
| New | +$1.94M |
|
|
DOOR
403
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $1.86M | 0.07% |
30,652
+1,702
| +6% | +$114K |
|
|
INVX
404
Innovex International
INVX
$1.79B
| $1.84M | 0.07% |
31,645
-4,213
| -12% | -$268K |
|
405
Electronic Arts
EA
$52.4B
| $1.83M | 0.07% |
27,080
+11,066
| +69% | +$776K |
|
|
AAWW
406
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
| $1.83M | 0.07% |
52,936
+32,464
| +159% | +$1.45M |
|
|
SUM
407
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $1.82M | 0.07% |
+102,850
| New | +$2.37M |
|
|
VGR
408
DELISTED
Vector Group Ltd.
VGR
| $1.82M | 0.07% |
137,993
-8,502
| -6% | -$115K |
|
409
Pacira BioSciences
PCRX
$1.05B
| $1.81M | 0.07% |
44,134
+34,722
| +369% | +$2.13M |
|
410
SiriusXM
SIRI
$10.7B
| $1.81M | 0.07% |
48,350
| – | – |
|
411
Toll Brothers
TOL
$14.5B
| $1.8M | 0.07% |
52,536
+26,336
| +101% | +$997K |
|
|
DHC
412
Diversified Healthcare Trust
DHC
$2.23B
| $1.8M | 0.07% |
111,964
-65,484
| -37% | -$1.08M |
|
413
CoStar Group
CSGP
$12.4B
| $1.79M | 0.07% |
103,750
+62,910
| +154% | +$1.2M |
|
414
Matsons
MATX
$6.15B
| $1.79M | 0.07% |
46,654
+15,544
| +50% | +$614K |
|
|
IDTI
415
DELISTED
Integrated Device Technology I
IDTI
| $1.78M | 0.07% |
87,679
-109,396
| -56% | -$2.14M |
|
416
Cousins Properties
CUZ
$5.22B
| $1.77M | 0.07% |
68,107
+4,924
| +8% | +$136K |
|
417
Gaming and Leisure Properties
GLPI
$13B
| $1.77M | 0.07% |
59,591
-19,575
| -25% | -$638K |
|
|
TECD
418
DELISTED
Tech Data Corp
TECD
| $1.76M | 0.07% |
+25,763
| New | +$1.58M |
|
|
GAS
419
DELISTED
AGL Resources Inc
GAS
| $1.76M | 0.07% |
28,816
-72,431
| -72% | -$3.88M |
|
|
FSL
420
DELISTED
FREESCALE SEMICONDUCTOR LTD
FSL
| $1.75M | 0.06% |
47,942
-14,936
| -24% | -$559K |
|
421
Veeco
VECO
$2.79B
| $1.75M | 0.06% |
85,448
+34,339
| +67% | +$829K |
|
422
Heron Therapeutics
HRTX
$92M
| $1.74M | 0.06% |
+71,138
| New | +$2.37M |
|
423
Enbridge
ENB
$121B
| $1.73M | 0.06% |
46,485
+10,806
| +30% | +$451K |
|
|
RPTP
424
DELISTED
RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
| $1.72M | 0.06% |
+284,454
| New | +$3.49M |
|
425
Minerals Technologies
MTX
$2.33B
| $1.72M | 0.06% |
35,638
+19,490
| +121% | +$1.13M |
|
Similar funds
MA
FFIM
LC
YEPV
AAM
CCM
IR
IFC
A.R.T. Advisors's Q3 2015 Portfolio in Review
As of Q3 2015, A.R.T. Advisors held 1,895 positions worth $2.7B, down 9.9% from $3B the previous quarter. Its ten largest holdings account for 8.3% of the portfolio.
A.R.T. Advisors's Q3 2015 filing shows 457 new, 377 increased, 454 reduced and 575 closed positions. Its largest new stake was Teva Pharmaceuticals: 414,963 shares worth $23.4M. The largest sale was Cencora, an estimated $22.3M.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Technology and Consumer Discretionary.
- A.R.T. Advisors's largest Q3 2015 buy was Teva Pharmaceuticals: 414,963 shares worth $23.4M.
- A.R.T. Advisors added most to Alphabet (Google) Class C in Q3 2015, an estimated $24.9M increase.
- A.R.T. Advisors's biggest Q3 2015 reduction was Cencora, cutting an estimated $22.3M.
- A.R.T. Advisors fully exited Alibaba in Q3 2015, selling an estimated $18.9M.
- A.R.T. Advisors's ten largest holdings make up 8.3% of its $2.7B portfolio in Q3 2015.
- A.R.T. Advisors opened 457 new positions and closed 575 in Q3 2015.
- A.R.T. Advisors's portfolio value fell 9.9% quarter-over-quarter to $2.7B.
Based on A.R.T. Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.